Evidence map›Paper›PMID 32291326›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy.

Ali M Alawieh, E Farris Langley, Wuwei Feng, Alejandro M Spiotta, Stephen Tomlinson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ali M AlawiehDepartment of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322 tomlinss@musc.edu aalawie@emory.edu.ORCID 0000-0003-2601-8850
E Farris LangleyDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina 29425.
Wuwei FengDepartment of Neurology, Duke University Medical Center, Durham, NC, 27710.
Alejandro M SpiottaDepartment of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina 29425.
Stephen TomlinsonDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina 29425 tomlinss@musc.edu aalawie@emory.edu.ORCID 0000-0002-6281-2122
Medical University of South Carolina · USDuke University · USEmory University · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
Treating Depression and Enhancing Locomotor Recovery Post-strokeP20GM109040 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KAUTZ, STEVEN A. · 2014 to 2024
$23.5M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Pilot and Feasibility Project ProgramP30GM103331 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKWOOD, KEITH L · 2012 to 2016
$5.2M
Confocal/Multiphoton Microscope UpgradeS10OD018113 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2015 to 2015
$570k
BLR&D Research Career Scientist Award Application for Dr. Stephen TomlinsonIK6BX005235 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2020 to 2024
–
Targeting complement and chronic inflammation after traumatic brain injuryI21RX002363 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2016 to 2018
–
Novel Therapies to Improve Functional Recovery After StrokeI01RX001141 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2014 to 2022
–
Role of complement in TBII01BX004256 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI Stephen Tomlinson · 2019 to 2026
–
BLRD VA I01 BX004256BLRD VA IK6 BX005235NCI NIH HHS P30 CA138313NIDDK NIH HHS P30 DK123704NIGMS NIH HHS P20 GM109040NIGMS NIH HHS P30 GM103331NIH HHS S10 OD018113RRD VA I01 RX001141RRD VA I21 RX002363
6 · The paper itself

Abstract

Despite the success of reperfusion therapy in significantly reducing the extent of infarct expansion after stroke, the effect of revascularization on poststroke neuroinflammation and the role of anti-inflammatory strategies in postreperfusion era are yet to be explored. Here, we investigate whether the neuroinflammatory response may still contribute to neurologic deficits after reperfused stroke by using targeted complement inhibition to suppress poststroke neuroinflammation in mice with or without concurrent reperfusion therapy. Complement inhibition was achieved using B4Crry, an injury site-targeted inhibitor of C3 activation. Following embolic stroke in male C57bl/6 mice, thrombolysis using tissue-plasminogen activator (t-PA) reduced injury and improved motor deficits, but did not improve cognitive outcomes. After both reperfused and non-reperfused stroke, complement activation and opsonization of hippocampal synapses directed ongoing microglia-dependent phagocytosis of synapses for at least 30 d after stroke, leading to a loss of synaptic density that was associated with cognitive decline. B4Crry treatment, alone or in combination with tPA, limited perilesional complement deposition, reduced microgliosis and synaptic uptake, and improved cognitive outcome without affecting regenerative responses. Furthermore, complement inhibition improved the safety, efficacy, and treatment window of reperfusion therapy with t-PA by limiting hemorrhagic transformation. This work thus demonstrates that poststroke neuroinflammation contributes to hemorrhagic transformation and progression of neurodegenerative responses in the brain even following early and successful revascularization.

Indexed as

AgedAged, 80 and overAnimalsCognitive DysfunctionComplement System ProteinsFemaleHumansInfarction, Middle Cerebral ArteryMaleMiceMice, Inbred C57BLMiddle AgedRecovery of FunctionReperfusionStrokeStroke RehabilitationComplement System ProteinsTissue Plasminogen Activatorcognitive outcomescomplementreperfusionstroketissue-plasminogen activator

Identifiers

PMID32291326
PMCPMC7219298
OpenAlexW3015679775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.